In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.
Ariey-Bonnet J, Carrasco K, Le Grand M, Hoffer L, Betzi S, Feracci M, Tsvetkov P, Devred F, Collette Y, Morelli X, Ballester P, Pasquier E
Biography I'm a passionate, enthusiastic and highly motivated early-career researcher. I'm interested in the development of novel and effective anticancer strategies. To do that, I combine my knowledge as a trained pharmacist with my understanding of cancer biology. My focus is mainly on childhood cancers.
Publications
Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration.
Po'uha ST, Le Grand M, Brandl MB, Gifford AJ, Goodall GJ, Khew-Goodall Y, Kavallaris M
Targeting Functional Activity of AKT Has Efficacy against Aggressive Neuroblastoma.
Le Grand M, Kimpton K, Gana CC, Valli E, Fletcher JI, Kavallaris M